US Nuclear Corp (OTC: UCLE) has filed its first-quarter 2026 financial report, revealing a 72% reduction in loss from operations compared to the same period in 2025. The improvement, amounting to over $375,000, offers a rare piece of positive financial news for the small-cap nuclear technology company, which has faced months of reporting delays and operational disruptions. The company expects to file its second-quarter report within three to four weeks, but its stock will not resume trading until after the third-quarter release, projected for the first week of December. The US Nuclear Form 10Q_March 31, 2026 provides the first detailed look at the company's performance under its new reporting regimen.
CFO Michael Hastings attributed the delays to the closure of the company's Los Angeles operation and the loss of key personnel, which made retrieving financial data difficult. The company also replaced staff at its Overhoff subsidiary and brought in a new auditor whose recommendations are still being implemented. The 2025 audit took far longer than expected, pushing subsequent quarterly filings past their deadlines; the first-quarter close and review process alone took about four months, well beyond the 45-day window. These delays have kept the stock from trading and raised questions about internal controls, making the filing of the US Nuclear Form 10K_December 31, 2025 a critical step toward restoring investor confidence.
Despite the reporting challenges, US Nuclear has taken several operational steps that management believes will make 2027 a record year. In June, the company hired a general manager and chief operating officer who is streamlining logistics, clearing backlogs, and accelerating product delivery. Backlog has grown to $1.2 million and is expected to reach $2.9 million by year-end. The company is also interviewing outsourced CPA firms to improve financial reporting accuracy and timeliness, with onboarding expected soon.
Additionally, the new GM is using four college interns to conduct a full marketing and product analysis of the TA/Optron product line, which was built in Los Angeles. The goal is to relaunch those products in January 2027 and add $600,000 in revenues. US Nuclear has also started discussions with other companies about potential joint ventures, an acquisition, or a reverse merger that would take the company public. Management projects sales and profits to increase 20-30% in 2027 and sales to double by 2028, or significantly higher if a transaction closes in 2027.
For investors, the narrowed loss is a concrete sign that cost-cutting and operational changes are gaining traction. However, the delayed filings and the stock's continued suspension mean shareholders cannot act on the news until the third-quarter report is released. The outcome of the CPA firm selection and the success of the TA/Optron relaunch will be key indicators of whether the company can sustain its momentum and meet its ambitious growth targets. The original release was distributed via www.newmediawire.com, and the company's forward-looking statements caution that macroeconomic changes, supply chain disruptions, and capital-raising risks could cause actual results to differ materially.
